Story thread · 2 reports / 1 sources
Ondine Biomedical reports phase 3 trial meets primary endpoint
investing.com · 5d
First report: Genflow meets primary endpoint in aged dog gene therapy trial — investing.com, 7d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.